Plain-English translation of NCT07214753 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The ATHENA study is tracking how works in real-world practice for adults with severe eosinophilic asthma—the kind of asthma driven by high levels of a specific white blood cell called eosinophils. Researchers want to learn whether this medication helps patients achieve remission (where asthma is well-controlled or nearly symptom-free) and how it changes the immune system. By collecting information from patients actually being treated with the medication, the study will provide practical evidence about its effectiveness and long-term safety.
Current research on this medication has mostly come from controlled clinical trials, but doctors need to understand how well it works for real patients in everyday practice—patients who may be older, have other health conditions, or take other medications. This study aims to fill that gap and help doctors better predict which patients will benefit most from this treatment.
You likely qualify if…
You likely don't qualify if…
As a participant, you will continue taking the medication as prescribed by your doctor—the study is not changing your treatment. Researchers will monitor your progress over time through clinic visits, collect information about how well your asthma is controlled, and take blood samples to measure changes in your immune system. The study will track your outcomes and safety data for as long as you continue the treatment, helping doctors understand how the medication works in practice.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Italy